{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:55:17Z","timestamp":1788926117819,"version":"build-2803163510"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"12","funder":[{"DOI":"10.13039\/100000054","name":"NCI National Institute of Diabetes NIH","doi-asserted-by":"publisher","award":["R01DK103794"],"award-info":[{"award-number":["R01DK103794"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI National Institute of Diabetes NIH","doi-asserted-by":"publisher","award":["UG1 CA233338"],"award-info":[{"award-number":["UG1 CA233338"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI National Institute of Diabetes NIH","doi-asserted-by":"publisher","award":["1U24CA224331-01"],"award-info":[{"award-number":["1U24CA224331-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI National Institute of Diabetes NIH","doi-asserted-by":"publisher","award":["P01CA206978"],"award-info":[{"award-number":["P01CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI National Institute of Diabetes NIH","doi-asserted-by":"publisher","award":["P01CA229092"],"award-info":[{"award-number":["P01CA229092"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001736","name":"German Research Foundation","doi-asserted-by":"publisher","award":["PE 3127\/1-1"],"award-info":[{"award-number":["PE 3127\/1-1"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NCI Research Specialist Award","award":["R50CA251956"],"award-info":[{"award-number":["R50CA251956"]}]},{"DOI":"10.13039\/501100001736","name":"German Research Foundation","doi-asserted-by":"publisher","award":["LU 2336\/2-1"],"award-info":[{"award-number":["LU 2336\/2-1"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA 213442"],"award-info":[{"award-number":["R01 CA 213442"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>While cancers evolve during disease progression and in response to therapy, temporal dynamics remain difficult to study in humans due to the lack of consistent barcodes marking individual clones in vivo. We employ mitochondrial single-cell assay for transposase-accessible chromatin with sequencing to profile 163,279 cells from 9 patients with chronic lymphocytic leukemia (CLL) collected across disease course and utilize mitochondrial DNA (mtDNA) mutations as natural genetic markers of cancer clones. We observe stable propagation of mtDNA mutations over years in the absence of strong selective pressure, indicating clonal persistence, but dramatic changes following tight bottlenecks, including disease transformation and relapse posttherapy, paralleled by acquisition of copy-number variants and changes in chromatin accessibility and gene expression. Furthermore, we link CLL subclones to distinct chromatin states, providing insight into nongenetic sources of relapse. mtDNA mutations thus mirror disease history and provide naturally occurring genetic barcodes to enable patient-specific study of cancer subclonal dynamics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Single-cell multi-omic profiling of CLL reveals the utility of somatic mtDNA mutations as in vivo barcodes, which mark subclones that can evolve over time along with changes in accessible chromatin and gene expression profiles to capture dynamics of disease evolution.<\/jats:p>\n                    <jats:p>See related commentary by Hilton and Scott, p. 2965.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 2945<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-21-0276","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T18:15:38Z","timestamp":1623348938000},"page":"3048-3063","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History"],"prefix":"10.1158","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-0207","authenticated-orcid":false,"given":"Livius","family":"Penter","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"4Department of Hematology, Oncology, Tumorimmunology, Campus Virchow Klinikum, Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyen H.","family":"Gohil","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"5Department of Academic Haematology, University College London Cancer Institute, London, United Kingdom."},{"name":"6Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-4807","authenticated-orcid":false,"given":"Caleb","family":"Lareau","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"7Division of Hematology\/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts."},{"name":"8Department of Pathology, Stanford University, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif S.","family":"Ludwig","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"7Division of Hematology\/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts."},{"name":"9Berlin Institute of Health at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany."},{"name":"10Berlin Institute for Medical Systems Biology, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-9769","authenticated-orcid":false,"given":"Erin M.","family":"Parry","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy","family":"Huang","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqiang","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandi","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-1446","authenticated-orcid":false,"given":"Dimitri","family":"Livitz","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignaty","family":"Leshchiner","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-5074","authenticated-orcid":false,"given":"Laxmi","family":"Parida","sequence":"additional","affiliation":[{"name":"12IBM TJ Watson Research Center, Yorktown Heights, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"13Cancer Center, Massachusetts General Hospital, Boston, Massachusetts."},{"name":"14Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[{"name":"15Moores Cancer Center, University of California San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"15Moores Cancer Center, University of California San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"16Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Davids","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"16Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"17Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-5856","authenticated-orcid":false,"given":"Kenneth J.","family":"Livak","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay G.","family":"Sankaran","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"7Division of Hematology\/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts."},{"name":"18Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5054","authenticated-orcid":false,"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"16Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2022060711363881100_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"2022060711363881100_bib2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1126\/science.1230184","article-title":"Epigenetic reprogramming in cancer","volume":"339","author":"Suv\u00e0","year":"2013","journal-title":"Science"},{"key":"2022060711363881100_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2011.03.020","article-title":"Genetic interactions in cancer progression and treatment","volume":"145","author":"Ashworth","year":"2011","journal-title":"Cell"},{"key":"2022060711363881100_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"2022060711363881100_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"2022060711363881100_bib6","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-017-02329-y","article-title":"The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy","volume":"8","author":"Landau","year":"2017","journal-title":"Nat Commun"},{"key":"2022060711363881100_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trecan.2018.01.001","article-title":"The genetic\/non-genetic duality of drug \u2018resistance\u2019 in cancer","volume":"4","author":"Salgia","year":"2018","journal-title":"Trends Cancer"},{"key":"2022060711363881100_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-019-1367-0","article-title":"Somatic mutations and cell identity linked by genotyping of transcriptomes","volume":"571","author":"Nam","year":"2019","journal-title":"Nature"},{"key":"2022060711363881100_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41588-019-0557-x","article-title":"Comprehensive molecular characterization of mitochondrial genomes in human cancers","volume":"52","author":"Yuan","year":"2020","journal-title":"Nat Genet"},{"key":"2022060711363881100_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s42255-021-00378-8","article-title":"Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA","volume":"3","author":"Gorelick","year":"2021","journal-title":"Nature Metab"},{"key":"2022060711363881100_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41587-020-0645-6","article-title":"Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling","volume":"39","author":"Lareau","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2022060711363881100_bib12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2019.01.022","article-title":"Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics","volume":"176","author":"Ludwig","year":"2019","journal-title":"Cell"},{"key":"2022060711363881100_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2022060711363881100_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMra1908213","article-title":"Treatment of chronic lymphocytic leukemia","volume":"383","author":"Burger","year":"2020","journal-title":"N Engl J Med"},{"key":"2022060711363881100_bib15","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2018-01-791376","article-title":"Biology and treatment of Richter syndrome","volume":"131","author":"Rossi","year":"2018","journal-title":"Blood"},{"key":"2022060711363881100_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrg3966","article-title":"The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease","volume":"16","author":"Stewart","year":"2015","journal-title":"Nat Rev Genet"},{"key":"2022060711363881100_bib17","doi-asserted-by":"crossref","first-page":"1.23.1","DOI":"10.1002\/0471250953.bi0123s44","article-title":"mtDNA variation and analysis using Mitomap and Mitomaster","volume":"44","author":"Lott","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"2022060711363881100_bib18","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1073\/pnas.0500563102","article-title":"Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease","volume":"102","author":"Kirino","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060711363881100_bib19","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.leu.2403043","article-title":"Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications","volume":"17","author":"Carew","year":"2003","journal-title":"Leukemia"},{"key":"2022060711363881100_bib20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00262-008-0486-5","article-title":"Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells","volume":"57","author":"Gr\u00fcnebach","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"2022060711363881100_bib21","doi-asserted-by":"crossref","first-page":"e1001376","DOI":"10.1371\/journal.pbio.1001376","article-title":"The germinal center kinase TNIK is required for canonical NF-\u03baB and JNK signaling in B Cells by the EBV oncoprotein LMP1 and the CD40 receptor","volume":"10","author":"Shkoda","year":"2012","journal-title":"PLoS Biol"},{"key":"2022060711363881100_bib22","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V106.11.2943.2943","article-title":"Expression of T cell co-stimulator (ICOS) and its ligand and disease progression in B-cell chronic lymphocytic leukemia","volume":"106","author":"Fukuda","year":"2005","journal-title":"Blood"},{"key":"2022060711363881100_bib23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature"},{"key":"2022060711363881100_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4161\/cc.9.3.10554","article-title":"Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression","volume":"9","author":"Castellano","year":"2010","journal-title":"Cell Cycle"},{"key":"2022060711363881100_bib25","doi-asserted-by":"crossref","first-page":"E2039","DOI":"10.1073\/pnas.1600557113","article-title":"Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2","volume":"113","author":"Hodson","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060711363881100_bib26","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/bloodadvances.2018019950","article-title":"Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B","volume":"2","author":"Batista","year":"2018","journal-title":"Blood Adv"},{"key":"2022060711363881100_bib27","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V98.12.3413","article-title":"The BCL11 gene family: involvement of BCL11A in lymphoid malignancies","volume":"98","author":"Satterwhite","year":"2001","journal-title":"Blood"},{"key":"2022060711363881100_bib28","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood-2017-12-820910","article-title":"Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study","volume":"131","author":"Ahn","year":"2018","journal-title":"Blood"},{"key":"2022060711363881100_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-019-14081-6","article-title":"Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL","volume":"11","author":"Rendeiro","year":"2020","journal-title":"Nat Commun"},{"key":"2022060711363881100_bib30","doi-asserted-by":"crossref","first-page":"e0229170","DOI":"10.1371\/journal.pone.0229170","article-title":"CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells","volume":"15","author":"Kozlova","year":"2020","journal-title":"PLoS One"},{"key":"2022060711363881100_bib31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"2022060711363881100_bib32","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/eji.201970107","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)","volume":"49","author":"Cossarizza","year":"2019","journal-title":"Eur J Immunol"},{"key":"2022060711363881100_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 controls follicular T helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"key":"2022060711363881100_bib34","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/JVI.02528-08","article-title":"Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure","volume":"83","author":"Harari","year":"2009","journal-title":"J Virol"},{"key":"2022060711363881100_bib35","doi-asserted-by":"crossref","first-page":"758\u201372","DOI":"10.1038\/s43018-021-00222-8","article-title":"Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment","volume":"2","author":"Gutierrez","year":"2021","journal-title":"Nat Cancer"},{"key":"2022060711363881100_bib36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/2326-6066.CIR-17-0012","article-title":"Clonal expansion and interrelatedness of distinct B-lineage compartments in multiple myeloma bone marrow","volume":"5","author":"Hansmann","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"2022060711363881100_bib37","doi-asserted-by":"crossref","first-page":"e1586409","DOI":"10.1080\/2162402X.2019.1586409","article-title":"Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer","volume":"8","author":"Penter","year":"2019","journal-title":"OncoImmunology"},{"key":"2022060711363881100_bib38","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/eji.201847507","article-title":"FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells","volume":"48","author":"Penter","year":"2018","journal-title":"Eur J Immunol"},{"key":"2022060711363881100_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41576-020-00284-x","article-title":"Extreme heterogeneity of human mitochondrial DNA from organelles to populations","volume":"22","author":"Stewart","year":"2021","journal-title":"Nat Rev Genet"},{"key":"2022060711363881100_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"key":"2022060711363881100_bib41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma","volume":"120","author":"Browne","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"2022060711363881100_bib42","doi-asserted-by":"crossref","first-page":"eabb7661","DOI":"10.1126\/scitranslmed.abb7661","article-title":"Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect","volume":"12","author":"Bachireddy","year":"2020","journal-title":"Sci Transl Med"},{"key":"2022060711363881100_bib43","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.18632\/oncotarget.3343","article-title":"Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"2022060711363881100_bib44","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-20-1145","article-title":"Evolution of the epigenetic landscape in childhood B acute lymphoblastic leukemia and its role in drug resistance","volume":"80","author":"Fleur-Lominy","year":"2020","journal-title":"Cancer Res"},{"key":"2022060711363881100_bib45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood.2019000854","article-title":"Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study","volume":"134","author":"Quinquenel","year":"2019","journal-title":"Blood"},{"key":"2022060711363881100_bib46","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2018-08-870238","article-title":"Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab","volume":"133","author":"Byrd","year":"2019","journal-title":"Blood"},{"key":"2022060711363881100_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41592-019-0691-5","article-title":"Single-cell multimodal omics: the power of many","volume":"17","author":"Zhu","year":"2020","journal-title":"Nat Methods"},{"key":"2022060711363881100_bib48","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41587-021-00927-2","article-title":"Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells","volume":"39","author":"Mimitou","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2022060711363881100_bib49","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"2022060711363881100_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","article-title":"ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis","volume":"53","author":"Granja","year":"2021","journal-title":"Nat Genet"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/11\/12\/3048\/3013069\/3048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/11\/12\/3048\/3013069\/3048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T12:34:09Z","timestamp":1672403649000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/11\/12\/3048\/674669\/Longitudinal-Single-Cell-Dynamics-of-Chromatin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-21-0276","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.6549383.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22540457.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22540460","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22540460.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6549383","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22540457","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}